Gumułka Paweł, Pecio Łukasz, Żmudzki Paweł, Ciura Krzesimir, Skalicka-Woźniak Krystyna, Dąbrowska Monika, Starek Małgorzata
Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, 16 Łazarza St., 31-530 Kraków, Poland.
Department of Inorganic and Analytical Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna St., 30-688 Kraków, Poland.
Pharmaceutics. 2023 Nov 9;15(11):2609. doi: 10.3390/pharmaceutics15112609.
Determining the influence of environmental factors on the stability of drugs is very helpful when choosing excipients, storage conditions or packaging materials. In addition, information about possible toxic degradation products enables detecting and avoiding the harmful side effects of the drug. We used the thin-layer chromatographic-densitometric procedure for the assay of five coxibs, conducted degradation studies in various environments and at different temperatures along with the determination of pharmacokinetic parameters. The results were subjected to chemometric analysis, to investigate and visualize the similarities and differences of the studied coxibs. Samples of the tested drug were also analyzed by UPLC-MS/MS in order to identify degradation products, and determine possible drug degradation pathways. Using the human liver cancer HepG2 cell line, the hepatotoxic effect of the degradation products was also determined. It was observed that all substances were relatively stable under the analyzed conditions and degraded more in acidic than alkaline environments. Robenacoxib is the drug that decomposes the fastest, and cimicoxib turned out to be the most stable. Robenacoxib also showed significant hepatotoxicity at the highest tested concentration, which correlates with the high degree of its degradation, and the probable formation of a more hepatoxic product. The obtained mass spectra of compounds formed as a result of hydrolysis of the protonated drug leading to the formation of several product ions, which enabled us to propose probable degradation pathways.
确定环境因素对药物稳定性的影响,对于选择辅料、储存条件或包装材料非常有帮助。此外,有关可能的有毒降解产物的信息有助于检测和避免药物的有害副作用。我们采用薄层色谱 - 密度测定法对五种环氧化酶 -2 抑制剂(coxibs)进行测定,在不同环境和温度下进行降解研究,并测定药代动力学参数。对结果进行化学计量学分析,以研究和可视化所研究的环氧化酶 -2 抑制剂的异同。还通过超高效液相色谱 - 串联质谱法(UPLC-MS/MS)分析受试药物样品,以鉴定降解产物并确定可能的药物降解途径。利用人肝癌HepG2细胞系,还测定了降解产物的肝毒性作用。观察到所有物质在分析条件下相对稳定,在酸性环境中比在碱性环境中降解更多。罗贝考昔是分解最快的药物,而西美考昔是最稳定的。罗贝考昔在最高测试浓度下也表现出显著的肝毒性,这与其高降解程度以及可能形成更具肝毒性的产物相关。质子化药物水解形成的化合物的质谱图显示形成了多个产物离子,这使我们能够提出可能的降解途径。